李伟超
《中国疗养医学》. 2017, 26(12): 0-0.
[Abstract] 0bjective To observe the clinical effect of HA330 hemoperfusion in patients with severe acute pancreatitis. Method 90 patients with severe acute pancreatitis in April 25, 2015 -2017 April 24th in our hospital, according to the different treatment methods are divided into two groups, 47 cases of application of conventional western medicine treated patients in the routine group, on the basis of conventional western medicine treatment for 43 cases of patients treated with hemoperfusion as the research group. The levels of inflammatory factors and immune function were observed in the two groups after treatment. Result The study group after treatment in patients with hs-CRP, IL-6, IL-8 and TNF- alpha level respectively (0.69 + 0.44) Mg, L-1 (4.57 + 1.16) PG, mL-1 (10.02 + 1.23) PG and mL-1 (7.56 + 2.08) PG, mL-1, CD4+ and CD4+/CD8+ respectively (42.54. 8.75)% and (2.10 + 0.78), normal group after treatment hs-CRP, IL-6, IL-8 and TNF- alpha level respectively (2.06 + 1.17) Mg, L-1 (8.03 + 2.24) PG, mL-1 (16.21 + 2.16) PG and mL-1 (18.25 + 4.93) PG - mL-1. CD4+ and CD4+/CD8+ levels were (30.62 + 8.59)% and (1.53 + 0.74). The difference between the two groups was statistically significant (P < 0.05). Conclusion HA330 hemoperfusion treatment of severe acute pancreatitis can reduce the level of inflammatory factors and enhance the level of immune cell subsets, and contribute to the alleviation of inflammation and immune function in patients.
